| CCY | SZE(M) | TNR | MTY | RNK | MO | SP | FI | TYPE | BNCH | IPT | GDNC | SPRD | CPN | NIC | PRICE |
|---|
| EUR | 1,140.000 | 2 | Sep-20 | Sr. Unsecured | Baa1 | BBB | - | Fixed | Swaps | MS+45 a | MS+25-30 | 25 | 0.00% | - | 99.72700 |
| EUR | 1,140.000 | 5 | Sep-23 | Sr. Unsecured | Baa1 | BBB | - | Fixed | Swaps | MS+75 a | MS+55-60 | 50 | 0.88% | - | 99.91200 |
| EUR | 1,140.000 | 8 | Sep-26 | Sr. Unsecured | Baa1 | BBB | - | Fixed | Swaps | MS+100 a | MS+75-80 | 75 | 1.50% | - | 99.72300 |
Tranche Comments
2 yr: Book size: 3100; Registration: Reg S Only; Comments: EUR1.14bn (upsized from EUR1bn) 2yr. Part of 3-trancher. Baa1/BBB. Barc(B&D)/BAML/JPM/MS. IPTs MS+45 area, guidance +25/+30 for 1.14bn size, tbp +25. Books closed 3.1bn+. OBL #171 4/20 +69.5 @100.874, HR 126%. PP: No. XD: No. Tax Call: No;
5 yr: Book size: 3900; Registration: Reg S Only; Comments: EUR1.14bn (upsized from EUR1bn) 5yr. Part of 3-trancher. Baa1/BBB. Barc(B&D)/BAML/JPM/MS. IPTs MS+75 area, guidance +55/+60 for 1.14bn, tbp +50. Books closed 3.9bn+. HR 93% vs DBR 2% Aug 2023+99.8 @110.317. PP: No. XD: No. Tax Call: No;
8 yr: Book size: 5200; Registration: Reg S Only; Comments: EUR1.14bn (upsized from EUR1bn) 8yr. Part of 3-trancher. Baa1/BBB. Barc(B&D)/BAML/JPM/MS. IPTs MS+100 area, guidance +75/+80 for 1.14bn, tbp +75. Books closed 5.2bn+. HR 97% vs DBR 0% Aug 2026+126.4 @97.877. PP: No. XD: No. Tax Call: No;
Guarantor(s)
Abbott Laboratories
Use of Proceeds
Repay notes